Clinical and histological features of poor prognosis in cutaneous metastatic melanomas

Journal of Cutaneous Pathology

Volumn 23, Issue 3, 1996, Pages 199-204

  Hofmann Wellenhof, R ^a   Woltsche Kahr, I ^a   Smolle, J ^a   Kerl, H ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; DERMIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PROGNOSIS; SKIN METASTASIS; STROMA; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029999254     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01467.x     Document Type: Article

References (22)

1. Fidler IJ. Origin and biology of cancer metastasis. Cytometry 1989: 10: 673.
2. Balch CM, Soong SJ, Shaw AM, Milton GW. An analysis of prognostic factors in 4000 patients with cutaneous melanoma. In: Balch CM, Milton GW, eds. Cutaneous melanoma. Clinical management and treatment results worldwide. Philadelphia: J. P. Lippincott Co., 1985: 321.
3. Häffner AC, Garbe C, Burg G, Büttner P, Orfanos CE, Rassner G. The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer 1992: 66: 856.
4. Balch CM, Soong S, Murad TM. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (STAGE III). Ann Surg 1983: 1: 126.
5. Markowitz JS, Cosimi LA, Carey RW et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 1991: 126: 703.
6. Evans GRD, Manson PN. Review and current perspectives of cutaneous malignant melanoma. J Am Coll Surg 1994: 178: 523.
7. Buzaid AC, Murren J. Chemotherapy for advanced malignant melanoma. Int J Clin Lab Res 1992: 21: 205.
8. Presant CA, Bartolucci AA. Prognostic factors in metastatic malignant melanoma. The Southeastern Cancer Study Group Experience. Cancer 1982: 49: 2192.
9. Clark WH, From L, Bernadino EA, Mihm MC. The histogenesis and biological behavior of human malignant melanomas of the skin. Cancer Res 1969: 29: 705.
10. Roses DF, Karp NS, Oratz R et al. Survival with regional and distant metastases from cutaneous malignant melanoma. Surg Gynecol Obstet 1991: 172: 262.
11. Fusi S, Ariyan S, Sternlicht A. Data on first recurrence after treatment for malignant melanoma in a large patient population. Plast Reconstr Surg 1993: 91: 94.
12. Smolle J, Woltsche I, Hofmann-Wellenhof R, Haas J, Kerl H. Pathology of tumor-stroma interaction in melanoma metastatic to the skin. Hum Pathol 1995: 26: 8561.
13. Schmoeckel C, Braun-Falco O. Prognostic index in malignant melanoma. Arch Dermatol 1978: 114: 871.
14. Smolle J, Hofmann-Wellenhof R, Soyer H-P, Stettner H, Kerl H. Nuclear size and shape parameters correlate with proliferative activity in cutaneous melanocytic tumors. J Invest Dermatol 1989: 93: 178.
15. Bortz J. Lehrbuch der Statistik für Sozialwissenschaftler. 2nd edn. Berlin,Heidelberg,New York,Tokyo: Springer, 1985.
16. Thörn M, Pontén F, Bergström R, Sparén P, Adami H-O. Clinical and histopathological predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994: 86: 761.
17. Berdeaux DH, Meyskens FL, Parks B, Tong T, Loescher L, Moon TE. Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease. Cancer 1989: 63: 1430.
18. Wanek LA, Elashoff RM, Goradia TM, Morton DL, Cochran AJ. Application of multistage Markow modeling to malignant melanoma progression. Cancer 1994: 73: 336.
19. Karakousis CP, Velez A, Driscoll DL, Takita H. Metastasectomy in malignant melanoma. Surgery 1994: 115: 295.
20. Baak JPA, Tan GJKH. The adjuvant prognostic value of nuclear morphometry in stage I malignant melanoma of the skin. A multivariate analysis. Analyt Quant Cytol Histol 1986: 8: 241.
21. Das Gupta T, Brasfield R. Metastatic melanoma. A clinico-pathological study. Cancer 1964: 17: 1323.
22. Heimdal K, Hannisdal E, Gundersell S. Regression analyses of prognostic factors in metastatic malignant melanoma. Eur J Cancer Clin Oncol 1989: 25: 1219.